Building the Foundation of Discovery
We collaborate with a network of internationally recognized preclinical research organizations that provide expertise in pharmacology, toxicology, and bioanalytical testing. These partnerships ensure our programs advance with the highest levels of scientific rigor, quality, and regulatory compliance, forming a strong foundation for every stage of development.
Partnerships fueling innovation and research
Our partners are key to our success and ongoing progress. These collaborations leverage the expertise, global reach, and innovative research capabilities of our partners, driving the development of our groundbreaking therapy.
Strategic partnerships driving innovation
Turning Data into Patient Impact
Our clinical and data partnerships bring together experienced global organizations specializing in clinical research, advanced analytics, and real-world evidence. Through these collaborations, we accelerate the transition from discovery to clinical application, ensuring patient safety, data integrity, and operational excellence remain at the heart of everything we do.
AI-Driven Peptide Therapeutics Innovation
Artificial intelligence (AI)-driven peptide design platforms are transforming peptide drug discovery by integrating advanced machine learning, molecular modeling, and computational chemistry. These technologies enable the design and optimization of novel peptide candidates at atomic resolution, accelerating discovery while reducing development timelines, costs, and the number of peptides that need to be synthesized and experimentally tested.
Partnering for a healthier future
By aligning with industry leaders and adopting cutting edge technology, Aqur is positioned to bring transformative cholesterol therapies to millions worldwide. Our partnerships are more than collaborations — they are key drivers of medical breakthroughs. Together, we are shaping the future of cardiovascular health.
